Former Life Technologies CEO Greg Lucier was named chairman and interim CEO of NuVasive following the resignation of Alex Lukianov. An internal investigation by the company's board found that Lukianov did not comply with NuVasive's expense reimbursement and other policies.
Lucier has been a board member of NuVasive since 2013. From 2003 to 2014 he was chairman and CEO of Life Techn before it was acquired by Thermo Fisher Scientific. Prior to Life Tech, he was a corporate officer at General Electric and an executive at GE Medical Systems.